Although the number of samples was small in this study, our results suggest that feline serum TK1 is a promising biomarker for feline cancer diagnosis and prognosis, for monitoring treatment of malignant diseases, and it may also be used to differentiate IBD from alimentary lymphoma, although future studies with more samples are necessary. This evidence concerns the gene TK1 and cancer.